DK26389D0 - 1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse - Google Patents

1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse

Info

Publication number
DK26389D0
DK26389D0 DK026389A DK26389A DK26389D0 DK 26389 D0 DK26389 D0 DK 26389D0 DK 026389 A DK026389 A DK 026389A DK 26389 A DK26389 A DK 26389A DK 26389 D0 DK26389 D0 DK 26389D0
Authority
DK
Denmark
Prior art keywords
piperidinyl compounds
disubstituted piperidinyl
disubstituted
compounds
piperidinyl
Prior art date
Application number
DK026389A
Other languages
English (en)
Other versions
DK26389A (da
Inventor
Albert A Carr
Francis P Miller
Thaddeus R Nieduzak
Stephen M Sorensen
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK26389D0 publication Critical patent/DK26389D0/da
Publication of DK26389A publication Critical patent/DK26389A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK026389A 1988-01-21 1989-01-20 1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse DK26389A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14664788A 1988-01-21 1988-01-21
US07/279,900 US5064838A (en) 1988-01-21 1988-12-07 1,4-disubstituted-piperidinyl compounds as pain relievers

Publications (2)

Publication Number Publication Date
DK26389D0 true DK26389D0 (da) 1989-01-20
DK26389A DK26389A (da) 1989-07-22

Family

ID=48782796

Family Applications (1)

Application Number Title Priority Date Filing Date
DK026389A DK26389A (da) 1988-01-21 1989-01-20 1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse

Country Status (18)

Country Link
US (1) US5064838A (da)
EP (1) EP0325268B1 (da)
JP (1) JP2967990B2 (da)
KR (1) KR0131377B1 (da)
CN (1) CN1035823A (da)
AR (2) AR247385A1 (da)
AT (1) ATE90077T1 (da)
AU (1) AU615713B2 (da)
CA (1) CA1330087C (da)
DE (1) DE68906801T2 (da)
DK (1) DK26389A (da)
ES (1) ES2058346T3 (da)
FI (1) FI90534C (da)
HU (2) HU205073B (da)
NO (1) NO174505B (da)
NZ (1) NZ227643A (da)
PH (1) PH27115A (da)
PT (1) PT89497B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
NZ236501A (en) * 1989-12-21 1992-12-23 Merrell Dow Pharma Piperidine derivatives and antithrombotic compositions
AU652759B2 (en) * 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol
DE69123052T2 (de) * 1990-06-07 1997-03-06 Merrell Pharma Inc Derivate des 1-piperidinyl-alkanoylarylsulfonamids
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
US5292726A (en) * 1991-05-22 1994-03-08 Merck & Co., Inc. N,N-diacylpiperazines
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US6048859A (en) 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US5387595A (en) * 1992-08-26 1995-02-07 Merck & Co., Inc. Alicyclic compounds as tachykinin receptor antagonists
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5348955A (en) * 1993-06-22 1994-09-20 Merck & Co., Inc. N,N-diacylpiperazines
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
EP0796619A1 (en) 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
PT958280E (pt) 1997-10-31 2005-09-30 Daiichi Suntory Pharma Co Ltd Derivados de arilpiperidinopropanol e arilpiperazinopropanol e farmacos contendo os mesmos
US6713627B2 (en) * 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US20050261341A1 (en) * 1998-03-13 2005-11-24 Aventis Pharmaceuticals Inc. Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6939879B2 (en) * 1998-08-28 2005-09-06 Aventis Pharmaceuticals Inc. Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia
US6277864B1 (en) 1998-08-28 2001-08-21 Aventis Pharmaceuticals Inc. Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
GB1402889A (en) * 1973-02-03 1975-08-13 Ciba Geigy Ag Piperidine derivatives
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
EP0325268A1 (en) 1989-07-26
ATE90077T1 (de) 1993-06-15
AR247385A1 (es) 1994-12-29
HUT52050A (en) 1990-06-28
NO890269D0 (no) 1989-01-20
DE68906801D1 (de) 1993-07-08
HU900238D0 (en) 1990-03-28
AU2868789A (en) 1989-07-27
AU615713B2 (en) 1991-10-10
FI890245A0 (fi) 1989-01-17
NO174505B (no) 1994-02-07
CN1035823A (zh) 1989-09-27
NO174505C (da) 1994-05-18
EP0325268B1 (en) 1993-06-02
CA1330087C (en) 1994-06-07
PT89497B (pt) 1994-03-31
DE68906801T2 (de) 1993-09-23
NZ227643A (en) 1991-01-29
PT89497A (pt) 1989-10-04
AR244666A1 (es) 1993-11-30
HUT53871A (en) 1990-12-28
KR0131377B1 (ko) 1998-04-17
JP2967990B2 (ja) 1999-10-25
JPH01224360A (ja) 1989-09-07
FI890245A (fi) 1989-07-22
NO890269L (no) 1989-07-24
PH27115A (en) 1993-03-16
ES2058346T3 (es) 1994-11-01
DK26389A (da) 1989-07-22
HU205073B (en) 1992-03-30
KR890011840A (ko) 1989-08-22
FI90534B (fi) 1993-11-15
FI90534C (fi) 1994-02-25
US5064838A (en) 1991-11-12
HU202494B (en) 1991-03-28

Similar Documents

Publication Publication Date Title
DK26389A (da) 1,4-disubstituerede piperidinyl-forbindelser og deres anvendelse
DK0384288T3 (da) Piperidinforbindelser og deres fremstilling og anvendelse
DK186489D0 (da) 1,3-disubstituerede pyrrolidiner, deres fremstilling og anvendelse
DK84689A (da) Piperidinderivater
KR900700567A (ko) 2,3-디플루오로비페닐
DK416985A (da) Substitueret 1,4-dihydropyridincarbonyl-piperidinoforbindelser samt deres fremstilling og anvendelse
DK623689A (da) Piperidinderivater
DK371088A (da) Azacykliske forbindelser, deres fremstilling og anvendelse
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DK494589D0 (da) Substituerede 1,3,5-triazintrioner og deres anvendelse samt mellemprodukter til deres fremstilling
DK425788D0 (da) 1,4-disubstituerede 1-azolyl-3,3-dimethylbutanderivater, fremgangsmaade til deres anvendelse samt deres anvendelse
DK393485D0 (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
NO176411C (no) Dörkarm
DK538385D0 (da) 1,4-dihydropyridiner, deres fremstilling og anvendelse
DK8887D0 (da) Substituerede 1,3,5-oxadiazin-2-oner samt deres fremstilling og anvendelse
NO892190L (no) Kompositt-materialer og deres anvendelse.
DK187689D0 (da) Piperidine forbindelser, deres fremstilling og anvendelse
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
DK426986D0 (da) Piperidine forbindelser, deres fremstilling og anvendelse
DK523286D0 (da) Piperidine forbindelser, deres fremstilling og anvendelse
NO923042D0 (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse
DK142088A (da) 4-phenyl-piperidine forbindelser, deres fremstilling og anvendelse
ATA34789A (de) Personenschleuse
KR900009587A (ko) 1, 4-디하이드로피리딘 유도체
NO894971D0 (no) Piperidinderivater.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment